* The introduction of iPCSK9 medications allowed some patients to stop lipoapheresis while still maintaining healthy cholesterol levels.
* A case study of a 27-year-old male with Congenital Muscular Dystrophy and Heterozygous Familial Hypercholesterolemia showed successful treatment with alirocumab, reducing cLDL levels effectively after discontinuing lipoapheresis.
PCT (Procalcitonin) is an important diagnostic tool for bacterial infections, but its effectiveness in elderly patients had not been extensively studied prior to this research.*
-
The study involved 161 elderly patients (75 years and older) split into two groups: one with probable bacterial infections and another with noninfectious diseases, to assess the validity of PCT levels in diagnosis.*
-
Results showed that PCT had a sensitivity of 72% and specificity of 92% for diagnosing bacterial infections in the elderly, indicating it can effectively help identify infections in this population.*